Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

B. E. P. J. Vriens; I. J. H. Vriens; M. J. B. Aarts; S. M. van Gastel; F. W. P. J. van den Berkmortel; T. J. Smilde; L. J. C. van Warmerdam; D. J. van Spronsen; P. G. M. Peer; M. de Boer; V. C. G. Tjan-Heijnen; Breast Canc Trialists Grp

doi:10.1007/s10549-017-4364-8

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

B. E. P. J. Vriens, I. J. H. Vriens, M. J. B. Aarts, S. M. van Gastel, F. W. P. J. van den Berkmortel, T. J. Smilde, L. J. C. van Warmerdam, D. J. van Spronsen, P. G. M. Peer, M. de Boer, V. C. G. Tjan-Heijnen^*, Breast Canc Trialists Grp

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Web of Science)

Original language	English
Pages (from-to)	593-600
Number of pages	8
Journal	Breast Cancer Research and Treatment
Volume	165
Issue number	3
DOIs	https://doi.org/10.1007/s10549-017-4364-8
Publication status	Published - Oct 2017

Keywords

Breast cancer
Neoadjuvant chemotherapy
Disease-free survival
Overall survival
SURGICAL ADJUVANT BREAST
CELL-DEATH
PHASE-III
DOCETAXEL
DOXORUBICIN
TRIAL
DOXORUBICIN/CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
ANTHRACYCLINE
THERAPY

Access to Document

10.1007/s10549-017-4364-8

Cite this

Vriens, B. E. P. J., Vriens, I. J. H., Aarts, M. J. B., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., van Spronsen, D. J., Peer, P. G. M., de Boer, M., Tjan-Heijnen, V. C. G., & Breast Canc Trialists Grp (2017). Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer. Breast Cancer Research and Treatment, 165(3), 593-600. https://doi.org/10.1007/s10549-017-4364-8

Vriens, B. E. P. J. ; Vriens, I. J. H. ; Aarts, M. J. B. ; van Gastel, S. M. ; van den Berkmortel, F. W. P. J. ; Smilde, T. J. ; van Warmerdam, L. J. C. ; van Spronsen, D. J. ; Peer, P. G. M. ; de Boer, M. ; Tjan-Heijnen, V. C. G. ; Breast Canc Trialists Grp. / Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer. In: Breast Cancer Research and Treatment. 2017 ; Vol. 165, No. 3. pp. 593-600.

@article{2428ca94e224430cb0b43eca7dc02dbd,

title = "Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer",

keywords = "Breast cancer, Neoadjuvant chemotherapy, Disease-free survival, Overall survival, SURGICAL ADJUVANT BREAST, CELL-DEATH, PHASE-III, DOCETAXEL, DOXORUBICIN, TRIAL, DOXORUBICIN/CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE, ANTHRACYCLINE, THERAPY",

author = "Vriens, {B. E. P. J.} and Vriens, {I. J. H.} and Aarts, {M. J. B.} and {van Gastel}, {S. M.} and {van den Berkmortel}, {F. W. P. J.} and Smilde, {T. J.} and {van Warmerdam}, {L. J. C.} and {van Spronsen}, {D. J.} and Peer, {P. G. M.} and {de Boer}, M. and Tjan-Heijnen, {V. C. G.} and {Breast Canc Trialists Grp}",

year = "2017",

month = oct,

doi = "10.1007/s10549-017-4364-8",

language = "English",

volume = "165",

pages = "593--600",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer, Cham",

number = "3",

}

Vriens, BEPJ, Vriens, IJH , Aarts, MJB, van Gastel, SM, van den Berkmortel, FWPJ, Smilde, TJ, van Warmerdam, LJC, van Spronsen, DJ, Peer, PGM, de Boer, M , Tjan-Heijnen, VCG & Breast Canc Trialists Grp 2017, 'Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer', Breast Cancer Research and Treatment, vol. 165, no. 3, pp. 593-600. https://doi.org/10.1007/s10549-017-4364-8

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer. / Vriens, B. E. P. J.; Vriens, I. J. H.; Aarts, M. J. B.; van Gastel, S. M.; van den Berkmortel, F. W. P. J.; Smilde, T. J.; van Warmerdam, L. J. C.; van Spronsen, D. J.; Peer, P. G. M.; de Boer, M.; Tjan-Heijnen, V. C. G.; Breast Canc Trialists Grp.

In: Breast Cancer Research and Treatment, Vol. 165, No. 3, 10.2017, p. 593-600.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

AU - Vriens, B. E. P. J.

AU - Vriens, I. J. H.

AU - Aarts, M. J. B.

AU - van Gastel, S. M.

AU - van den Berkmortel, F. W. P. J.

AU - Smilde, T. J.

AU - van Warmerdam, L. J. C.

AU - van Spronsen, D. J.

AU - Peer, P. G. M.

AU - de Boer, M.

AU - Tjan-Heijnen, V. C. G.

AU - Breast Canc Trialists Grp

PY - 2017/10

Y1 - 2017/10

KW - Breast cancer

KW - Neoadjuvant chemotherapy

KW - Disease-free survival

KW - Overall survival

KW - SURGICAL ADJUVANT BREAST

KW - CELL-DEATH

KW - PHASE-III

KW - DOCETAXEL

KW - DOXORUBICIN

KW - TRIAL

KW - DOXORUBICIN/CYCLOPHOSPHAMIDE

KW - CYCLOPHOSPHAMIDE

KW - ANTHRACYCLINE

KW - THERAPY

U2 - 10.1007/s10549-017-4364-8

DO - 10.1007/s10549-017-4364-8

M3 - Article

VL - 165

SP - 593

EP - 600

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -